{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:48:53Z","timestamp":1757702933970},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00347-008-1700-8","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T09:23:02Z","timestamp":1207300982000},"page":"405-419","source":"Crossref","is-referenced-by-count":15,"title":["Schleimhautpemphigoid mit okul\u00e4rer Beteiligung"],"prefix":"10.1007","volume":"105","author":[{"given":"T.","family":"Meyer-ter-Vehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,6]]},"reference":[{"key":"1700_CR1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","volume":"16","author":"Aberer","year":"1987","unstructured":"Aberer W, Wolff-Schreiner EC, Stingl G et al. (1987) Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol 16: 527\u2013533","journal-title":"J Am Acad Dermatol"},{"key":"1700_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"Austin","year":"1986","unstructured":"Austin HA, 3rd, Klippel JH, Balow JE et al. (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614\u2013619","journal-title":"N Engl J Med"},{"key":"1700_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0161-6420(02)01892-4","volume":"110","author":"Barabino","year":"2003","unstructured":"Barabino S, Rolando M, Bentivoglio G et al. (2003) Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 110: 474\u2013480","journal-title":"Ophthalmology"},{"key":"1700_CR4","doi-asserted-by":"crossref","unstructured":"Broadway D (1997) Management of glaucoma in patients with chronic progressive conjunctival cicatrisation. In: Bernauer W, Dart J, Elder M (eds) Cicatrising conjunctivitis. Karger, Basel, pp 240\u2013241","DOI":"10.1159\/000060700"},{"key":"1700_CR5","first-page":"370","volume":"138","author":"Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ et al. (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138: 370\u2013379","journal-title":"Arch Dermatol"},{"key":"1700_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08820530590931368","volume":"20","author":"Dart","year":"2005","unstructured":"Dart J (2005) Cicatricial pemphigoid and dry eye. Semin Ophthalmol 20: 95\u2013100","journal-title":"Semin Ophthalmol"},{"key":"1700_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.1974.tb06383.x","volume":"90","author":"Dave","year":"1974","unstructured":"Dave VK, Vickers CF (1974) Azathioprine in the treatment of muco-cutaneous pemphigoid. Br J Dermatol 90: 183\u2013186","journal-title":"Br J Dermatol"},{"key":"1700_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(99)90022-2","volume":"106","author":"Donnenfeld","year":"1999","unstructured":"Donnenfeld ED, Perry HD, Wallerstein A et al.(1999) Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 106: 72\u201378","journal-title":"Ophthalmology"},{"key":"1700_CR9","first-page":"83","volume":"48","author":"Dua","year":"2000","unstructured":"Dua HS, Saini JS, Azuara-Blanco A et al. (2000) Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol 48: 83\u201392","journal-title":"Indian J Ophthalmol"},{"key":"1700_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bjo.78.10.769","volume":"78","author":"Elder","year":"1994","unstructured":"Elder MJ, Bernauer W (1994) Cryotherapy for trichiasis in ocular cicatricial pemphigoid. Br J Ophthalmol 78: 769\u2013771","journal-title":"Br J Ophthalmol"},{"key":"1700_CR11","unstructured":"Elder MJ, Collin JRO (1997) Lid surgery: the management of cicatricial entropion and trichiasis. In: Bernauer W, Dart J K G, Elder MJ (eds) Cicatrising conjunctivitis. Karger, Basel, pp 207\u2013218"},{"key":"1700_CR12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bjo.79.3.264","volume":"79","author":"Elder","year":"1995","unstructured":"Elder MJ, Lightman S, Dart JK (1995) Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol 79: 264\u2013266","journal-title":"Br J Ophthalmol"},{"key":"1700_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.80.4.292","volume":"80","author":"Elder","year":"1996","unstructured":"Elder MJ, Bernauer W, Leonard J et al. (1996) Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 80: 292\u2013296","journal-title":"Br J Ophthalmol"},{"key":"1700_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bjo.80.6.549","volume":"80","author":"Elder","year":"1996","unstructured":"Elder MJ, Leonard J, Dart JK (1996) Sulphapyridine \u2013 a new agent for the treatment of ocular cicatricial pemphigoid. Br J Ophthalmol 80: 549\u2013552","journal-title":"Br J Ophthalmol"},{"key":"1700_CR15","first-page":"527","volume":"84","author":"Foster","year":"1986","unstructured":"Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84: 527\u2013663","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1700_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","volume":"89","author":"Foster","year":"1982","unstructured":"Foster CS, Wilson LA, Ekins MB (1982) Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 89: 340\u2013353","journal-title":"Ophthalmology"},{"key":"1700_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00160769","volume":"82","author":"Foster","year":"1992","unstructured":"Foster CS, Neumann R, Tauber J (1992) Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid. Doc Ophthalmol 82: 223\u2013229","journal-title":"Doc Ophthalmol"},{"key":"1700_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/08820530590931377","volume":"20","author":"Geerling","year":"2005","unstructured":"Geerling G, Borrelli M (2005) Adnexal surgery for severe ocular surface disease. Semin Ophthalmol 20: 101\u2013112","journal-title":"Semin Ophthalmol"},{"key":"1700_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/PL00007877","volume":"238","author":"Geerling","year":"2000","unstructured":"Geerling G, Dart JK (2000) Management and outcome of cataract surgery in ocular cicatricial pemphigoid. Graefes Arch Clin Exp Ophthalmol 238: 112\u2013118","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1700_CR20","first-page":"948","volume":"42","author":"Geerling","year":"2001","unstructured":"Geerling G, Daniels JT, Dart JK et al. (2001) Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42: 948\u2013956","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1700_CR21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/bjo.86.11.1220","volume":"86","author":"Geerling","year":"2002","unstructured":"Geerling G, Liu CS, Collin JR et al. (2002) Costs and gains of complex procedures to rehabilitate end stage ocular surface disease. Br J Ophthalmol 86: 1220\u20131221","journal-title":"Br J Ophthalmol"},{"key":"1700_CR22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00347-005-1284-5","volume":"102","author":"Geerling","year":"2005","unstructured":"Geerling G, Duncker GI, Krumeich J et al. (2005) Lamell\u00e4re Keratoplastik: Zur\u00fcck in die Zukunft? Ophthalmologe 102: 1140\u20131148, 1150\u20131151","journal-title":"Ophthalmologe"},{"key":"1700_CR23","doi-asserted-by":"crossref","unstructured":"Geerling G, Raus P, Murube J (2008) Transplantation of minor salivary glands. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/000131093"},{"key":"1700_CR24","doi-asserted-by":"crossref","unstructured":"Geerling G, Sieg P, Murube J (2008) Transplantation of major salivary glands. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/000131094"},{"key":"1700_CR25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archopht.121.10.1369","volume":"121","author":"Gomes","year":"2003","unstructured":"Gomes JA, Santos MS, Ventura AS et al. (2003) Amniotic membrane with living related corneal limbal\/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome. Arch Ophthalmol 121: 1369\u20131374","journal-title":"Arch Ophthalmol"},{"key":"1700_CR26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archderm.139.8.1083","volume":"139","author":"Hall","year":"2003","unstructured":"Hall VC, Liesegang TJ, Kostick DA et al. (2003) Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 139: 1083\u20131084","journal-title":"Arch Dermatol"},{"key":"1700_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00347-004-1101-6","volume":"102","author":"Hanisch","year":"2005","unstructured":"Hanisch KT, Neppert B, Geerling G (2005) Gasdurchl\u00e4ssige Sklerallinsen als konservative Therapiealternative bei extremen Hornhautektasien und schwerem Tr\u00e4nenmangel. Ophthalmologe 102: 387\u2013392","journal-title":"Ophthalmologe"},{"key":"1700_CR28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0161-6420(93)31487-9","volume":"100","author":"Heiligenhaus","year":"1993","unstructured":"Heiligenhaus A, Shore JW, Rubin PA et al. (1993) Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Implications for patient selection and surgical considerations. Ophthalmology 100: 1283\u20131288","journal-title":"Ophthalmology"},{"key":"1700_CR29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-2005-858455","volume":"222","author":"Heiligenhaus","year":"2005","unstructured":"Heiligenhaus A, Bonsmann G, Heinz C et al. (2005) Empfehlungen zu Diagnostik und Therapie beim Schleimhautpemphigoid am Auge. Klin Monatsbl Augenheilkd 222: 689\u2013703","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1700_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.bor.0000200369.24793.f5","volume":"18","author":"Hellmich","year":"2006","unstructured":"Hellmich B, Lamprecht P, Gross WL (2006) Advances in the therapy of Wegener\u2019s granulomatosis. Curr Opin Rheumatol 18: 25\u201332","journal-title":"Curr Opin Rheumatol"},{"key":"1700_CR31","doi-asserted-by":"crossref","unstructured":"Henderson H, Collin J (2008) Mucous membrane grafting. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/000131092"},{"key":"1700_CR32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.ico.0000157401.81408.62","volume":"24","author":"Hille","year":"2005","unstructured":"Hille K, Grabner G, Liu C et al. (2005) Standards for modified osteoodontokeratoprosthesis (OOKP) surgery according to Strampelli and Falcinelli: the Rome-Vienna Protocol. Cornea 24: 895\u2013908","journal-title":"Cornea"},{"key":"1700_CR33","doi-asserted-by":"crossref","unstructured":"Hintschich C (2008) Correction of en- and ectropion. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/000131075"},{"key":"1700_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2005.09.003","volume":"141","author":"Inatomi","year":"2006","unstructured":"Inatomi T, Nakamura T, Koizumi N et al. (2006) Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am J Ophthalmol 141: 267\u2013275","journal-title":"Am J Ophthalmol"},{"key":"1700_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0151-9638(05)79188-2","volume":"132","author":"Ingen-Housz-Oro","year":"2005","unstructured":"Ingen-Housz-Oro S, Prost-Squarcioni C, Pascal F et al. (2005) [Cicatricial pemphigoid: treatment with mycophenolate mofetil]. Ann Dermatol Venereol 132: 13\u201316","journal-title":"Ann Dermatol Venereol"},{"key":"1700_CR36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS et al. (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130: 492\u2013513","journal-title":"Am J Ophthalmol"},{"key":"1700_CR37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2003.09.034","volume":"111","author":"Kaido","year":"2004","unstructured":"Kaido M, Goto E, Dogru M et al. (2004) Punctal occlusion in the management of chronic Stevens-Johnson syndrome. Ophthalmology 111: 895\u2013900","journal-title":"Ophthalmology"},{"key":"1700_CR38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.exer.2003.09.004","volume":"78","author":"Kinoshita","year":"2004","unstructured":"Kinoshita S, Koizumi N, Nakamura T (2004) Transplantable cultivated mucosal epithelial sheet for ocular surface reconstruction. Exp Eye Res 78: 483\u2013491","journal-title":"Exp Eye Res"},{"key":"1700_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.138.3.380","volume":"138","author":"Kirtschig","year":"2002","unstructured":"Kirtschig G, Murrell D, Wojnarowska F et al. (2002) Interventions for mucous membrane pemphigoid\/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 138: 380\u2013384","journal-title":"Arch Dermatol"},{"key":"1700_CR40","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200565130-00003","volume":"65","author":"Laforest","year":"2005","unstructured":"Laforest C, Huilgol SC, Casson R et al. (2005) Autoimmune bullous diseases: ocular manifestations and management. Drugs 65: 1767\u20131779","journal-title":"Drugs"},{"key":"1700_CR41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0161-6420(95)30835-4","volume":"102","author":"Lane","year":"1995","unstructured":"Lane L, Tamesis R, Rodriguez A et al. (1995) Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. Ophthalmology 102: 1530\u20131535","journal-title":"Ophthalmology"},{"key":"1700_CR42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s004170100306","volume":"239","author":"Letko","year":"2001","unstructured":"Letko E, Ahmed AR, Foster CS (2001) Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). Graefes Arch Clin Exp Ophthalmol 239: 441\u2013444","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1700_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archopht.119.5.659","volume":"119","author":"Letko","year":"2001","unstructured":"Letko E, Stechschulte SU, Kenyon KR et al. (2001) Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 119: 659\u2013663","journal-title":"Arch Ophthalmol"},{"key":"1700_CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","volume":"111","author":"Letko","year":"2004","unstructured":"Letko E, Miserocchi E, Daoud YJ et al. (2004) A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 111: 303\u2013310","journal-title":"Clin Immunol"},{"key":"1700_CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.ico.0000244877.30997.6a","volume":"26","author":"Mansour","year":"2007","unstructured":"Mansour K, Leonhardt CJ, Kalk WW et al. (2007) Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis sicca caused by Sjogren syndrome: a uniocular evaluation. Cornea 26: 147\u2013150","journal-title":"Cornea"},{"key":"1700_CR46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","volume":"111","author":"McCluskey","year":"2004","unstructured":"McCluskey P, Chang JH, Singh R et al. (2004) Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology 111: 796\u2013801","journal-title":"Ophthalmology"},{"key":"1700_CR47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s003470050021","volume":"97","author":"Messmer","year":"2000","unstructured":"Messmer EM, Hintschich CR, Partscht K et al. (2000) [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications]. Ophthalmologe 97: 113\u2013120","journal-title":"Ophthalmologe"},{"key":"1700_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0151-9638(06)70869-9","volume":"133","author":"Michel","year":"2006","unstructured":"Michel JL, Gain P (2006) [Topical tacrolimus treatment for ocular cicatricial pemphigoid]. Ann Dermatol Venereol 133: 161\u2013164","journal-title":"Ann Dermatol Venereol"},{"key":"1700_CR49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","volume":"96","author":"Mondino","year":"1983","unstructured":"Mondino BJ, Brown SI (1983) Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96: 453\u2013459","journal-title":"Am J Ophthalmol"},{"key":"1700_CR50","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ophtha.2006.09.034","volume":"114","author":"Nakamura","year":"2007","unstructured":"Nakamura T, Inatomi T, Cooper LJ et al. (2007) Phenotypic investigation of human eyes with transplanted autologous cultivated oral mucosal epithelial sheets for severe ocular surface diseases. Ophthalmology 114: 1080\u20131088","journal-title":"Ophthalmology"},{"key":"1700_CR51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0161-6420(91)32209-7","volume":"98","author":"Neumann","year":"1991","unstructured":"Neumann R, Tauber J, Foster CS (1991) Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 98: 858\u2013862","journal-title":"Ophthalmology"},{"key":"1700_CR52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","volume":"88","author":"Noble","year":"2004","unstructured":"Noble BA, Loh RS, MacLennan S et al. (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88: 647\u2013652","journal-title":"Br J Ophthalmol"},{"key":"1700_CR53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(02)01932-2","volume":"110","author":"Papaliodis","year":"2003","unstructured":"Papaliodis GN, Chu D, Foster CS (2003) Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 110: 786\u2013789","journal-title":"Ophthalmology"},{"key":"1700_CR54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"Pflugfelder","year":"2004","unstructured":"Pflugfelder SC (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137: 337\u2013432","journal-title":"Am J Ophthalmol"},{"key":"1700_CR55","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","volume":"85","author":"Poon","year":"2001","unstructured":"Poon AC, Geerling G, Dart JK et al. (2001) Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85: 1188\u20131197","journal-title":"Br J Ophthalmol"},{"key":"1700_CR56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00003226-199711000-00003","volume":"16","author":"Pullum","year":"1997","unstructured":"Pullum KW, Buckley RJ (1997) A study of 530 patients referred for rigid gas permeable scleral contact lens assessment. Cornea 16: 612\u2013622","journal-title":"Cornea"},{"key":"1700_CR57","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.ophtha.2006.03.065","volume":"113","author":"Resch","year":"2006","unstructured":"Resch MD, Schlotzer-Schrehardt U, Hofmann-Rummelt C et al. (2006) Integration patterns of cryopreserved amniotic membranes into the human cornea. Ophthalmology 113: 1927\u20131935","journal-title":"Ophthalmology"},{"key":"1700_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","volume":"6","author":"Rogers","year":"1982","unstructured":"Rogers RS, 3rd, Seehafer JR, Perry HO (1982) Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 6: 215\u2013223","journal-title":"J Am Acad Dermatol"},{"key":"1700_CR59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0896-1549(02)00067-6","volume":"16","author":"Rosenthal","year":"2003","unstructured":"Rosenthal P, Cotter J (2003) The Boston scleral lens in the management of severe ocular surface disease. Ophthalmol Clin North Am 16: 89\u201393","journal-title":"Ophthalmol Clin North Am"},{"key":"1700_CR60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0161-6420(88)33162-3","volume":"95","author":"Sainz","year":"1988","unstructured":"Sainz de la Maza M, Tauber J, Foster CS (1988) Cataract surgery in ocular cicatricial pemphigoid. Ophthalmology 95: 481\u2013486","journal-title":"Ophthalmology"},{"key":"1700_CR61","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0161-6420(02)00994-6","volume":"109","author":"Samson","year":"2002","unstructured":"Samson CM, Nduaguba C, Baltatzis S et al. (2002) Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109: 862\u2013868","journal-title":"Ophthalmology"},{"key":"1700_CR62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","volume":"115","author":"Saw","year":"2008","unstructured":"Saw VP, Dart JK, Rauz S et al. (2008) Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology 115: 253\u2013261","journal-title":"Ophthalmology"},{"key":"1700_CR63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","volume":"31","author":"Schmidt","year":"2006","unstructured":"Schmidt E, Hunzelmann N, Zillikens D et al. (2006) Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol 31: 503\u2013508","journal-title":"Clin Exp Dermatol"},{"key":"1700_CR64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","volume":"156","author":"Schmidt","year":"2007","unstructured":"Schmidt E, Seitz CS, Benoit S et al. (2007) Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 156: 352\u2013356","journal-title":"Br J Dermatol"},{"key":"1700_CR65","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00417-006-0257-y","volume":"244","author":"Schrader","year":"2006","unstructured":"Schrader S, Wedel T, Moll R et al. (2006) Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol 244: 1345\u20131349","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1700_CR66","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00347-003-0861-8","volume":"100","author":"Schroder","year":"2003","unstructured":"Schroder C, Hakim SG, Collin JR et al. (2003) Mehrjahresverlauf nach Autotransplantation der Unterkieferspeicheldr\u00fcse bei vernarbender Keratokonjunktivitis mit absolutem Tr\u00e4nenmangel. Ophthalmologe 100: 1079\u20131084","journal-title":"Ophthalmologe"},{"key":"1700_CR67","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-9394(14)70495-7","volume":"122","author":"Secchi","year":"1996","unstructured":"Secchi AG, Tognon MS (1996) Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 122: 728\u2013730","journal-title":"Am J Ophthalmol"},{"key":"1700_CR68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0161-6420(02)00960-0","volume":"109","author":"Solomon","year":"2002","unstructured":"Solomon A, Ellies P, Anderson DF et al. (2002) Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109: 1159\u20131166","journal-title":"Ophthalmology"},{"key":"1700_CR69","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0161-6420(88)33009-5","volume":"95","author":"Soong","year":"1988","unstructured":"Soong HK, Martin NF, Wagoner MD et al. (1988) Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study. Ophthalmology 95: 1442\u20131446","journal-title":"Ophthalmology"},{"key":"1700_CR70","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003226-199503000-00002","volume":"14","author":"Tan","year":"1995","unstructured":"Tan DT, Pullum KW, Buckley RJ (1995) Medical applications of scleral contact lenses: 2. Gas-permeable scleral contact lenses. Cornea 14: 130\u2013137","journal-title":"Cornea"},{"key":"1700_CR71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0161-6420(89)32942-3","volume":"96","author":"Tauber","year":"1989","unstructured":"Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96: 33\u201337","journal-title":"Ophthalmology"},{"key":"1700_CR72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","volume":"10","author":"Tauber","year":"1991","unstructured":"Tauber J, Sainz de la Maza M, Foster CS (1991) Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 10: 185\u2013195","journal-title":"Cornea"},{"key":"1700_CR73","doi-asserted-by":"crossref","unstructured":"Tost F, Geerling G (2008) Punctal plugs. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/isbn.978-3-8055-8377-0"},{"key":"1700_CR74","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","volume":"25","author":"Tsai","year":"2006","unstructured":"Tsai JH, Derby E, Holland EJ et al. (2006) Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 25: 530\u2013532","journal-title":"Cornea"},{"key":"1700_CR75","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ophtha.2004.11.041","volume":"112","author":"Tseng","year":"2005","unstructured":"Tseng SC, Di Pascuale MA, Liu DT et al. (2005) Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112: 896\u2013903","journal-title":"Ophthalmology"},{"key":"1700_CR76","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","volume":"106","author":"Tsubota","year":"1999","unstructured":"Tsubota K, Goto E, Shimmura S et al. (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106: 1984\u20131989","journal-title":"Ophthalmology"},{"key":"1700_CR77","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(95)30980-3","volume":"102","author":"Tugal-Tutkun","year":"1995","unstructured":"Tugal-Tutkun I, Akova YA, Foster CS (1995) Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 102: 576\u2013585","journal-title":"Ophthalmology"},{"key":"1700_CR78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bjo.84.3.279","volume":"84","author":"Wenkel","year":"2000","unstructured":"Wenkel H, Rummelt V, Naumann GO (2000) Long term results after autologous nasal mucosal transplantation in severe mucus deficiency syndromes. Br J Ophthalmol 84: 279\u2013284","journal-title":"Br J Ophthalmol"},{"key":"1700_CR79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003226-200101000-00003","volume":"20","author":"Yaghouti","year":"2001","unstructured":"Yaghouti F, Nouri M, Abad JC et al. (2001) Keratoprosthesis: preoperative prognostic categories. Cornea 20: 19\u201323","journal-title":"Cornea"},{"key":"1700_CR80","doi-asserted-by":"crossref","unstructured":"Yokoi N, Inatomi T, Kinoshita S (2008) Surgery of the conjunctiva. In: Geerling G, Brewitt H (eds) Surgery for the dry eye. Karger, Basel","DOI":"10.1159\/000131086"},{"key":"1700_CR81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2001-14917","volume":"218","author":"Zurdel","year":"2001","unstructured":"Zurdel J, Aboalchamat B, Zierhut M et al. (2001) Erste klinische Erfahrungen mit Mycophenolatmofetil bei der immunsuppressiven Therapie des okul\u00e4ren Pemphigoids. Klin Monatsbl Augenheilkd 218: 222\u2013228","journal-title":"Klin Monatsbl Augenheilkd"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-008-1700-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1700-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:51Z","timestamp":1559051451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-008-1700-8"}},"subtitle":["Teil II: Therapie"],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1007\/s00347-008-1700-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}